口服非肽类胰高血糖素样肽-1(GLP-1)激动剂,它的优势是非肽类,在胃肠道不容易被分解,可以与食物一起服用。
Orforglipron (LY-3502970) is an oral, non-peptide, small molecule glucagon-like peptide-1 receptor agonist developed as a weight loss drug by Eli Lilly and Company.[1][2] It is easier to produce than current peptide GLP-1 agonists and is expected to be cheaper.[3]
德州佳泰化工科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
德州佳泰化工